Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
07 Novembro 2023 - 9:30AM
Business Wire
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
technology marketed and sold as Renuvion®, announced today that
management will participate in the following upcoming investor
conferences:
The Stephens Annual Investment Conference at the Nashville
Grand Hyatt in Nashville, TN
- Management will participate in a fireside chat on Tuesday,
November 14 at 12:00 p.m. Eastern Time.
The Craig-Hallum 14th Annual Alpha Select Conference at the
Sheraton NY Times Square Hotel in New York, NY
- Management will participate in 1x1 meetings on Thursday,
November 16. There will be no formal presentation.
The Piper Sandler 35th Annual Healthcare Conference at the
Lotte New York Palace in New York, NY
- Management will participate in a fireside chat on Wednesday,
November 29 at 4:00 p.m. Eastern Time.
Audio webcasts of the fireside chat will be provided under the
‘Company Events’ section of the Apyx Medical Corporation investor
relations website at https://apyxmedical.com/investor_relations/.
The webcasts will be achieved and available for replay following
the conferences.
About Apyx Medical
Corporation:
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Technology
products marketed and sold as Renuvion in the cosmetic surgery
market and J-Plasma® in the hospital surgical market. Renuvion and
J-Plasma offer surgeons a unique ability to provide controlled heat
to tissue to achieve their desired results. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through OEM agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Apyx Medical Corporation website at
www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231107620849/en/
Investor Relations: ICR
Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Apyx Medical (NASDAQ:APYX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024